Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

被引：0
|
作者：
Goki Suda
Mineo Kudo
Atsushi Nagasaka
Ken Furuya
Yoshiya Yamamoto
Tomoe Kobayashi
Keisuke Shinada
Miki Tateyama
Jun Konno
Yoko Tsukuda
Kazushi Yamasaki
Megumi Kimura
Machiko Umemura
Takaaki Izumi
Seiji Tsunematsu
Fumiyuki Sato
Katsumi Terashita
Masato Nakai
Hiromasa Horimoto
Takuya Sho
Mitsuteru Natsuizaka
Kenichi Morikawa
Koji Ogawa
Naoya Sakamoto
机构：
[1] Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] Hokkaido University,undefined
[3] Sapporo Hokuyu Hospital,undefined
[4] Sapporo City General Hospital,undefined
[5] JCHO Hokkaido Hospital,undefined
[6] Hakodate City Hospital,undefined
[7] Tomakomai City Hospital,undefined
[8] Keiwakai Ebetsu Hospital,undefined
[9] Tomakomai Nissho Hospital,undefined
[10] Hakodate Central General Hospital,undefined
来源：
Journal of Gastroenterology | 2016年 / 51卷
关键词：
HCV; Hemodialysis; Daclatasvir; Asunaprevir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 740
页数：7
相关论文
共 50 条
  • [41] Three cases of the hepatitis C patients that presented hyperkalemia during daclatasvir and asunaprevir combination therapy
    Ohyama, Tatsuya
    Yamazaki, Yuichi
    Hashizume, Hiroaki
    Horiguchi, Norio
    Sato, Ken
    Kakizaki, Satoru
    Kusano, Motoyasu
    Yamada, Masanobu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 377 - 378
  • [42] Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients
    Morio, Kei
    Imamura, Michio
    Kawakami, Yoshiiku
    Morio, Reona
    Kobayashi, Tomoki
    Yokoyama, Satoe
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Makokha, Grace Naswa
    Hayes, C. Nelson
    Aikata, Hiroshi
    Miki, Daiki
    Ochi, Hidenori
    Honda, Yoji
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (03) : 645 - 650
  • [43] Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir
    Huang, Chung-Feng
    Yeh, Ming-Lun
    Huang, Ching-, I
    Liang, Po-Cheng
    Lin, Yi-Hun
    Hsieh, Ming-Yen
    Chen, Kuan-Yu
    Ko, Yu-Min
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (01) : 151 - 156
  • [44] Early response and efficacy of dual oral therapy with asunaprevir and daclatasvir for elderly patients with hepatitis C
    Honda, Takashi
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Hayashi, Kazuhiko
    Hirooka, Yoshiki
    Goto, Hidemi
    HEPATOLOGY, 2015, 62 : 786A - 786A
  • [45] Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1
    Iio, Etsuko
    Shimada, Noritomo
    Abe, Hiroshi
    Atsukawa, Masanori
    Yoshizawa, Kai
    Takaguchi, Koichi
    Eguchi, Yuichiro
    Nomura, Hideyuki
    Kuramitsu, Tomoyuki
    Kang, Jong-Hon
    Matsui, Takeshi
    Hirashima, Noboru
    Tsubota, Akihito
    Kusakabe, Atsunori
    Hasegawa, Izumi
    Miyaki, Tomokatsu
    Shinkai, Noboru
    Fujiwara, Kei
    Nojiri, Shunsuke
    Tanaka, Yasuhito
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (01) : 94 - 103
  • [46] Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1
    Etsuko Iio
    Noritomo Shimada
    Hiroshi Abe
    Masanori Atsukawa
    Kai Yoshizawa
    Koichi Takaguchi
    Yuichiro Eguchi
    Hideyuki Nomura
    Tomoyuki Kuramitsu
    Jong-Hon Kang
    Takeshi Matsui
    Noboru Hirashima
    Akihito Tsubota
    Atsunori Kusakabe
    Izumi Hasegawa
    Tomokatsu Miyaki
    Noboru Shinkai
    Kei Fujiwara
    Shunsuke Nojiri
    Yasuhito Tanaka
    Journal of Gastroenterology, 2017, 52 : 94 - 103
  • [47] Efficacy and safety of a fixed dose combination tablet of asunaprevir plus beclabuvir plus daclatasvir for the treatment of Hepatitis C
    Zappulo, Emanuela
    Scotto, Riccardo
    Buonomo, Antonio Riccardo
    Maraolo, Alberto Enrico
    Pinchera, Biagio
    Gentile, Ivan
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (03) : 261 - 273
  • [48] Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy
    Iio, Etsuko
    Shimada, Noritomo
    Takaguchi, Koichi
    Senoh, Tomonori
    Eguchi, Yuichiro
    Atsukawa, Masanori
    Tsubota, Akihito
    Abe, Hiroshi
    Kato, Keizo
    Kusakabe, Atsunori
    Miyaki, Tomokatsu
    Matsuura, Kentaro
    Matsunami, Kayoko
    Shinkai, Noboru
    Fujiwara, Kei
    Nojiri, Shunsuke
    Tanaka, Yasuhito
    HEPATOLOGY RESEARCH, 2017, 47 (12) : 1308 - 1316
  • [49] Successful achievement of sustained virological response to triple combination therapy containing simeprevir in two patients with chronic hepatitis C who had failed asunaprevir:Daclatasvir combination therapy
    Ozeki, Itaru
    Nakajima, Tomoaki
    Yamaguchi, Masakatsu
    Kimura, Mutsuumi
    Arakawa, Tomohiro
    Kuwata, Yasuaki
    Ohmura, Takumi
    Sato, Takahiro
    Hige, Shuhei
    Karino, Yoshiyasu
    Toyota, Joji
    HEPATOLOGY RESEARCH, 2016, 46 (11) : 1162 - 1167
  • [50] The efficacy and the adverse effect in the early stage of daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in Miyazaki, Japan
    Nakamura, Kenichi
    Nagata, Kenji
    Yamada, Yuuri
    Ohzono, Yoshinori
    Tsuchimochi, Mai
    Iwakiri, Hisayoshi
    Hasuike, Satoru
    Shimoda, Kazuya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 383 - 384
12345